View Dividend이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 피드백을 환영합니다!Femtobiomed 관리관리 기준 확인 0/4현재 CEO에 대한 정보가 충분하지 않습니다.주요 정보 최고 경영자n/a총 보상CEO 급여 비율n/aCEO 임기no dataCEO 소유권n/a경영진 평균 재임 기간데이터 없음이사회 평균 재임 기간데이터 없음최근 관리 업데이트업데이트 없음모든 업데이트 표시Recent updatesFemtobiomed Inc. announced that it has received KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.Apr 24Femtobiomed Inc. announced that it expects to receive KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.Mar 26New major risk - Share price stability Feb 02New major risk - Share price stability Oct 21Femtobiomed Inc. announced that it has received KRW 5.9999868 billion in fundingFeb 27+ 1 more updateFemtobiomed Inc. announced that it expects to receive KRW 5.9999868 billion in fundingFeb 11New 90-day low: ₩16,450 Oct 16New 90-day high - ₩20,500 Aug 07CEOFemtobiomed 에는 CEO가 없거나 그에 대한 데이터가 없습니다.View Ownership
Femtobiomed Inc. announced that it has received KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.Apr 24
Femtobiomed Inc. announced that it expects to receive KRW 2.999996625 billion in funding from Korea Investment Partners Co. Ltd.Mar 26
Femtobiomed Inc. announced that it has received KRW 5.9999868 billion in fundingFeb 27+ 1 more update